Jiangsu Aidea Pharmaceutical Group Co., Ltd.SSE: 688488

(688488)"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Plan for Repurchasing Shares through Call Auction

Oct 30, 2026 · Issued by Jiangsu Aidea Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688488 · Oct 30, 2026

On 6ix: 6ix.com/news/688488jiangsu-aidea-pharmaceutical-group-co-ltdplan-for-repurchasing-shares-through-call-auction

Plan for Repurchasing Shares through Call Auction

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Jiangsu Aidea Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Jiangsu Aidea Pharmaceutical

(688488)"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Voluntary Disclosure of Receipt of the Drug Clinical Trial Approval Notice for ACC085 TabletsOct 28
(688488)"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Notice on Convening the 2nd Extraordinary General Meeting in 2026Oct 27
(688488)"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Proposed Deregistration of Wholly-owned SubsidiaryOct 17
(688488)"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Approval Notice for ADC118 TabletsOct 16
Announcement on Signing the Supplementary Agreement to Conditional Stock Subscription Contract with a Specific Investor and Related Party TransactionSep 18

All Jiangsu Aidea Pharmaceutical news releases

Follow Jiangsu Aidea Pharmaceutical into a list and get an email when it puts out news.

Follow Jiangsu Aidea Pharmaceutical